Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 18, 2025 • 8:01 AM ET

Date/Time Source News Release
06/11/2025 09:00 AM EDT GlobeNewswire Fate Therapeutics Announces Updated Clinical Data for FT819 Off-the-shelf CAR T-cell Product Candidate Demonstrating Durability of Drug-free Remission for Severe Lupus Nephritis at EULAR 2025 Congress
05/30/2025 04:30 PM EDT GlobeNewswire Fate Therapeutics Appoints Matthew Abernethy, M.B.A., to its Board of Directors
05/28/2025 05:54 PM EDT GlobeNewswire Fate Therapeutics Announces Phase 1 Data Presentation of FT819 Off-the-Shelf CAR T-cell Product Candidate for SLE at EULAR 2025 Congress
05/13/2025 04:01 PM EDT GlobeNewswire Fate Therapeutics Reports First Quarter 2025 Financial Results and Business Updates
05/02/2025 04:01 PM EDT GlobeNewswire Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
04/29/2025 09:25 AM EDT GlobeNewswire Fate Therapeutics Announces Five Presentations on Off-the-Shelf CAR T-cell Product Platform at ASGCT Annual Meeting
04/14/2025 08:00 AM EDT GlobeNewswire Fate Therapeutics Receives Regenerative Medicine Advanced Therapy (RMAT) Designation from FDA for FT819 to Treat Moderate to Severe Systemic Lupus Erythematosus (SLE)
04/02/2025 04:01 PM EDT GlobeNewswire Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
03/05/2025 04:01 PM EST GlobeNewswire Fate Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates
03/04/2025 04:01 PM EST GlobeNewswire Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
Page

Additional News

As of June 18, 2025 • 8:01 AM ET

Date/Time Source News Release
06/12/2025 11:30 AM EDT Zacks Why Is Fate Therapeutics (FATE) Up 61.5% Since Last Earnings Report?
06/10/2025 10:23 AM EDT Zacks Top Cancer Stocks to Supercharge Your 2025 Portfolio
05/19/2025 11:10 AM EDT Baystreet This Natural Killer Treatment Could Help Transform How Cancer is Treated
05/14/2025 11:41 AM EDT Zacks Fate Therapeutics' Q1 Earnings & Revenues Beat, Pipeline in Focus
05/13/2025 05:54 PM EDT SeekingAlpha Fate Therapeutics GAAP EPS of -$0.32 beats by $0.07, revenue of $1.63M beats by $0.45M
05/13/2025 05:15 PM EDT Zacks Fate Therapeutics (FATE) Reports Q1 Loss, Tops Revenue Estimates
05/08/2025 06:22 PM EDT SeekingAlpha Fate Therapeutics: Suffering The Fate Of A Depressed Cell Therapy Sector
05/08/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Thursday, May 8th, 2025
05/08/2025 05:31 AM EDT US Earnings Reports Expected earnings - Fate Therapeutics Inc.
04/15/2025 10:42 AM EDT Zacks Fate Therapeutics' Lupus Candidate FT819 Gets FDA RMAT Tag
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.